Dow Down 0.22% Nasdaq Up 0.14%

Novogen Limited (NVGN)

-NasdaqCM
3.17 Down 0.03(0.94%) Aug 22, 3:58PM EDT
Prev Close:3.20
Open:3.15
Bid:3.15 x 1200
Ask:3.19 x 100
1y Target Est:N/A
Beta:-0.04
Next Earnings Date:N/A
Day's Range:3.15 - 3.20
52wk Range:2.72 - 6.84
Volume:5,147
Avg Vol (3m):43,207
Market Cap:20.48M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVGN

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):41.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novogen Limited operates as a pharmaceutical drug development company worldwide. It focuses on the development of a family of anti-cancer drugs based on super-benzopyran and stealth drug technologies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback